“The Reply to the Letter to the Editor Regarding: ‘The Autologous CaTeVac Dendritic Cell Vaccine in Patients with Melanoma: Final Results of the DENDRON-01 Study’” (2026) Voprosy onkologii, 72(1), p. OF-2568. doi:10.37469/0507-3758-2026-72-1-OF-2568.